These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33334620)

  • 41. [Aconitine ameliorates cardiomyocyte hypertrophy induced by angiotensin Ⅱ].
    Wang NN; Wang J; Tan HL; Wang YG; Gao Y; Ma ZC
    Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(8):1642-1647. PubMed ID: 31090329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.
    Diniz GP; Carneiro-Ramos MS; Barreto-Chaves ML
    Basic Res Cardiol; 2009 Nov; 104(6):653-67. PubMed ID: 19588183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Sirt3‑autophagy and resveratrol activation on myocardial hypertrophy and energy metabolism.
    Wang HN; Li JL; Xu T; Yao HQ; Chen GH; Hu J
    Mol Med Rep; 2020 Aug; 22(2):1342-1350. PubMed ID: 32468001
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Muscle A-kinase-anchoring protein-β-bound calcineurin toggles active and repressive transcriptional complexes of myocyte enhancer factor 2D.
    Li J; Aponte Paris S; Thakur H; Kapiloff MS; Dodge-Kafka KL
    J Biol Chem; 2019 Feb; 294(7):2543-2554. PubMed ID: 30523159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. VEGFB-VEGFR1 ameliorates Ang II-induced cardiomyocyte hypertrophy through Ca
    Shen Z; Zhang Z; Wang X; Yang K
    J Cell Biochem; 2018 Feb; 119(2):1511-1520. PubMed ID: 28771828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sodium butyrate attenuates angiotensin II-induced cardiac hypertrophy by inhibiting COX2/PGE2 pathway via a HDAC5/HDAC6-dependent mechanism.
    Zhang L; Deng M; Lu A; Chen Y; Chen Y; Wu C; Tan Z; Boini KM; Yang T; Zhu Q; Wang L
    J Cell Mol Med; 2019 Dec; 23(12):8139-8150. PubMed ID: 31565858
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FAK-related nonkinase attenuates hypertrophy induced by angiotensin-II in cultured neonatal rat cardiac myocytes.
    Qin J; Liu ZX
    Acta Pharmacol Sin; 2006 Sep; 27(9):1159-64. PubMed ID: 16923336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Involvement of ERK5 and JNK in the BMP9-induced differentiation of C3H10T1/2 cells into cardiomyocyte-like cells].
    Geng X; Liu S; Chen Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):829-32, 840. PubMed ID: 25108436
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angiotensin-(3-7) alleviates isoprenaline-induced cardiac remodeling via attenuating cAMP-PKA and PI3K/Akt signaling pathways.
    Zhang Y; Shang Z; Liu A
    Amino Acids; 2021 Oct; 53(10):1533-1543. PubMed ID: 34494132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angiotensin II Facilitates Matrix Metalloproteinase-9-Mediated Myosin Light Chain Kinase Degradation in Pressure Overload-Induced Cardiac Hypertrophy.
    Wang S; Cheng M; Hu Z; Hu S; Zou Q; Lai X; Liu B; Jiang H; Huang C; Wu G
    Cell Physiol Biochem; 2017; 44(6):2281-2295. PubMed ID: 29262413
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of ACE2 in cardiac myocytes and fibroblasts.
    Gallagher PE; Ferrario CM; Tallant EA
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2373-9. PubMed ID: 18849338
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiotensin-(1-7) stimulates high atrial pacing-induced ANP secretion via Mas/PI3-kinase/Akt axis and Na+/H+ exchanger.
    Shah A; Gul R; Yuan K; Gao S; Oh YB; Kim UH; Kim SH
    Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1365-74. PubMed ID: 20190099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
    Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
    Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
    [TBL] [Abstract][Full Text] [Related]  

  • 54. G1 cyclins are involved in the mechanism of cardiac myocyte hypertrophy induced by angiotensin II.
    Nozato T; Ito H; Tamamori M; Adachi S; Abe S; Marumo F; Hiroe M
    Jpn Circ J; 2000 Aug; 64(8):595-601. PubMed ID: 10952156
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
    Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
    Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heme oxygenase-1 gene transfer inhibits angiotensin II-mediated rat cardiac myocyte apoptosis but not hypertrophy.
    Foo RS; Siow RC; Brown MJ; Bennett MR
    J Cell Physiol; 2006 Oct; 209(1):1-7. PubMed ID: 16826603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heparin and heparan sulfate block angiotensin II-induced hypertrophy in cultured neonatal rat cardiomyocytes. A possible role of intrinsic heparin-like molecules in regulation of cardiomyocyte hypertrophy.
    Akimoto H; Ito H; Tanaka M; Adachi S; Hata M; Lin M; Fujisaki H; Marumo F; Hiroe M
    Circulation; 1996 Feb; 93(4):810-6. PubMed ID: 8641011
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quercetin inhibits left ventricular hypertrophy in spontaneously hypertensive rats and inhibits angiotensin II-induced H9C2 cells hypertrophy by enhancing PPAR-γ expression and suppressing AP-1 activity.
    Yan L; Zhang JD; Wang B; Lv YJ; Jiang H; Liu GL; Qiao Y; Ren M; Guo XF
    PLoS One; 2013; 8(9):e72548. PubMed ID: 24039778
    [TBL] [Abstract][Full Text] [Related]  

  • 59. sRAGE attenuates angiotensin II-induced cardiomyocyte hypertrophy by inhibiting RAGE-NFκB-NLRP3 activation.
    Lim S; Lee ME; Jeong J; Lee J; Cho S; Seo M; Park S
    Inflamm Res; 2018 Aug; 67(8):691-701. PubMed ID: 29796842
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase.
    Stuck BJ; Lenski M; Böhm M; Laufs U
    J Biol Chem; 2008 Nov; 283(47):32562-9. PubMed ID: 18790741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.